"Unser frei-gemeinnütziges Krankenhaus befindet sich mit über 225 Betten in der Kasseler Innenstadt. Medizinische Einrichtungen auf dem neusten Stand der Technik, wie Herzkatheterlabor, OP-Säle, Labor, Endoskopieabteilung, digitales Röntgen und viele weitere Einrichtungen stehen Ihnen zur Verfügung. Prägend für unser Haus ist die Orientierung an einem christlichen Menschenbild: Leib und Seele, Körper und Psyche bilden eine untrennbare Einheit im Heilungsprozess. Deshalb stehen wir Ihnen medizinisch wie seelsorgerisch zur Seite."

During the past decade, Elisabeth Krankenhaus conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elisabeth Krankenhaus" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Elisabeth Krankenhaus" are "Breast Cancer" (3 trials), "BRCA 1 /2 and / or HRD" (1 trials), "HER2-negative Breast Cancer" (1 trials), "HRpos Breast Neoplasms" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Elisabeth Krankenhaus" in a lesser frequency.

Most popular intervention types in "Elisabeth Krankenhaus" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "EC" (1 trials) and "FEC→T" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elisabeth Krankenhaus" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Elisabeth Krankenhaus". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Elisabeth Krankenhaus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Elisabeth Krankenhaus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".